GB1351342A - Quinoxaline derivatives - Google Patents

Quinoxaline derivatives

Info

Publication number
GB1351342A
GB1351342A GB3069171A GB3069171A GB1351342A GB 1351342 A GB1351342 A GB 1351342A GB 3069171 A GB3069171 A GB 3069171A GB 3069171 A GB3069171 A GB 3069171A GB 1351342 A GB1351342 A GB 1351342A
Authority
GB
United Kingdom
Prior art keywords
together signify
taken together
june
alkyl
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3069171A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of GB1351342A publication Critical patent/GB1351342A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/42—Benzopyrazines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

1351342 Quinoxaline derivatives CIBAGEIGY AG 30 June 1971 [6 July 1970 4 June 1971] 30691/71 Heading C2C Novel compounds (I) (including salts, optical isomers and racemates thereof) where R 1 and R 2 are H, alkyl, alkoxy, halogen, CF 3 or NO 2 or taken together signify alkylenedioxy, R 3 and R 4 are optionally substituted amidino, a monovalent or taken together signify a divalent optionally substituted hydrocarbon or acyl residue separating the sulphur atoms by at most 4 carbons or R 3 and R 4 together signify a direct bond, R 5 and R 6 are H or alkyl or taken together signify -(CH 2 ) n - where n is 1 to 8, are made by standard methods, especially utilizing the corresponding 2,3-bis-(bromomethyl or -mercaptomethyl) - quinoxalines; eyelizations are also utilized. Pharmaceutical preparations especially active against viruses contain (I) as active ingredient; administration may be enterally, parenterally or topically.
GB3069171A 1970-07-06 1971-06-30 Quinoxaline derivatives Expired GB1351342A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1015970 1970-07-06
CH820271 1971-06-04

Publications (1)

Publication Number Publication Date
GB1351342A true GB1351342A (en) 1974-04-24

Family

ID=25702964

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3069171A Expired GB1351342A (en) 1970-07-06 1971-06-30 Quinoxaline derivatives

Country Status (11)

Country Link
AT (2) AT312624B (en)
AU (1) AU3087571A (en)
BE (1) BE769491A (en)
DE (1) DE2132175A1 (en)
ES (1) ES392918A1 (en)
FR (1) FR2100864B1 (en)
GB (1) GB1351342A (en)
HU (1) HU165503B (en)
IE (1) IE35421B1 (en)
IL (1) IL37213A0 (en)
NL (1) NL7109266A (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE612972A (en) * 1958-07-10 1900-01-01
US3507870A (en) * 1968-12-18 1970-04-21 Pfizer & Co C 1,4-disubstituted-1,2,3,4-tetrahydrophenazine-5,10-dioxides

Also Published As

Publication number Publication date
HU165503B (en) 1974-09-28
BE769491A (en) 1972-01-05
IE35421B1 (en) 1976-02-04
AT312624B (en) 1974-01-10
DE2132175A1 (en) 1972-01-13
FR2100864B1 (en) 1974-09-06
IE35421L (en) 1971-12-06
FR2100864A1 (en) 1972-03-24
AU3087571A (en) 1973-01-17
IL37213A0 (en) 1971-10-20
ES392918A1 (en) 1974-07-01
NL7109266A (en) 1972-01-10
AT317228B (en) 1974-08-26

Similar Documents

Publication Publication Date Title
GB1203691A (en) New disubstituted n-amino indoline derivatives and process for preparing them
GB1334138A (en) Immunological adjuvatns
GB1285016A (en) 3,4-dihydroisoquinoline derivatives
FR2430418A1 (en) HALOGENOMETHYL DERIVATIVES OF A-AMINO ACIDS, THEIR PREPARATION AND THEIR THERAPEUTIC USES
GB1148586A (en) Improvements in or relating to anguidine derivatives
FR2397385A1 (en) RESORCINOL DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USES
FR2355007A1 (en) (3-LOWER ALCOYL-AMINO-2-R, 10 SUBSTITUTED PROPOXY PYRIDINES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
GB1351342A (en) Quinoxaline derivatives
FR2442226A1 (en) SUBSTITUTED ANILINES, THEIR PREPARATION AND THEIR USES
FR2421179A1 (en) 3-0- (B-D-GLUCURONOPYRANNOSYL) -SOYASAPOGENOL B, ITS PREPARATION AND ITS THERAPEUTIC USES
FR2361352A1 (en) ACYLAMINO (ALKYL) -BENZENIC DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION
FR2367761A1 (en) PIPERIDYLIDENIC DERIVATIVES OF BENZO-XANTHENS,
GB1363658A (en) Benzobicycloalkane compounds
GB1256723A (en)
FR2381030A1 (en) 2-PHENYLAMINOMETHYL IMIDAZOLINES AND THEIR PREPARATION
GB1242160A (en) Isoquinolines
FR2372792A1 (en) AMINOALCOXYBENZENES, THEIR PREPARATION AND THEIR THERAPEUTIC USES
FR2401922A1 (en) 4-HYDROXY-ISOPHTHALIC ACID SUBSTITUTE PICOLYLAMIDES, THEIR PREPARATION AND THERAPEUTIC USES
FR2372164A1 (en) PYRIDOBENZODIAZEPINONES, THEIR PREPARATION AND THEIR THERAPEUTIC USES
FR2433516A1 (en) PYRIDOXINS, THEIR PREPARATION AND THEIR THERAPEUTIC USES
FR2391189A1 (en) 2-AMINOTETRALINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USES
FR2395989A1 (en) DIPHENYL DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USES
FR2361393A1 (en) (2-AZABICYCLO (2.2.2) OCTANE-2-YL) DIPHENYLALCANONES AND DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USES, ESPECIALLY AS ANTI-DIARRHEA
FR2390435A1 (en) THIOBENZYLPYRIMIDINES, THEIR PREPARATION AND THEIR THERAPEUTIC USES
ES273933A1 (en) Pyrimethamine salt with 2, 6-dihydroxyisonicotinic acid

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PLNP Patent lapsed through nonpayment of renewal fees